Neo Cytamen (Hydroxocobalamin)

Hydroxocobalamin, the active ingredient in Neo Cytamen, is a Cobalamin (Vitamin B12) presented as a standard pharmaceutical preparation for intramuscular, intravenous, and oral use. It is employed to correct vitamin B12 deficiency and to treat cyanide poisoning in patients of all ages and is widely used in clinical practice.

GNH USA supplies Neo Cytamen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Hydroxocobalamin acts as a vitamin B12 supplement, addressing metabolic pathways that require cobalamin for DNA synthesis, red blood cell maturation, and detoxification of cyanide.

- Vitamin B12 deficiency: restores normal red blood cell formation, supports DNA synthesis, and improves neurological function in deficient individuals. - Cyanide poisoning: rapidly binds cyanide ions to form non‑toxic cyanocobalamin, facilitating swift detoxification and reversal of cyanide‑induced cellular hypoxia. - Pernicious anemia: supplies cobalamin to patients lacking intrinsic factor, aiding hematologic recovery and preventing neurologic complications associated with this autoimmune condition.

Hydroxocobalamin may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain or swelling: mild discomfort or erythema at the site of intramuscular or intravenous administration. - Nausea or vomiting: transient gastrointestinal upset occurring shortly after dosing. - Headache: mild to moderate headache that usually resolves without intervention. - Transient reddish discoloration of urine: harmless coloration due to excreted hydroxocobalamin.

Serious or Rare Side Effects: - Anaphylaxis or severe allergic reaction: rapid onset of hives, airway swelling, or circulatory collapse requiring emergency care. - Sudden hypotension: marked drop in blood pressure possibly leading to dizziness or fainting. - Acute hemolysis: rapid destruction of red blood cells, presenting with dark urine and fatigue.

When using Hydroxocobalamin, several precautionary measures should be observed to ensure safety and effectiveness. - Assess B12 status: confirm deficiency or poisoning before initiating therapy. - Monitor for hypersensitivity: observe patients for signs of allergic reaction during and after administration. - Caution in renal impairment: adjust dosing and monitor renal function as the drug is renally excreted. - Use with care in pregnancy: limited data; weigh potential benefits against unknown risks. - Avoid in known hypersensitivity to cobalamin: contraindicated in patients with documented allergy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Hydroxocobalamin can interact with certain medicines, affecting absorption or potentiating effects.

Major Interactions (Avoid): - Metformin: may mask B12 deficiency, requiring periodic monitoring. - Proton pump inhibitors: reduce gastric acidity, potentially decreasing oral B12 absorption. - Nitrous oxide anesthesia: can inactivate cobalamin, increasing risk of deficiency.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenytoin, carbamazepine): may lower B12 levels, necessitating periodic assessment. - Chemotherapy agents (e.g., methotrexate): concurrent use may require B12 status monitoring. - Folate supplements: high doses may mask hematologic signs of B12 deficiency.